The focus group conversations gripped me. I could not sleep at night, wrestling with the stories of trauma, shame and guilt the men shared. As the stories rattled me and the focus group participants, a new narrative began to unfold: reclaiming an old story of HIV to creating a new horizon of possibility and hope.
The babies? father, Aiden*, is HIV positive (a fact that remains unknown to most of the couple’s loved ones), but with medication, Zoey was able to remain virus-free and successfully conceive and deliver two perfectly healthy babies with Aiden.
Three-and-a-half years ago, the U.S. Food and Drug Administration approved the HIV treatment drug Truvada as pre-exposure prophylaxis or PrEP for HIV prevention. It was a landmark moment in the decades-long effort to halt HIV transmission. This pill, when taken daily by an HIV-negative person, reduces the likelihood of acquiring HIV by more than 90 percent.
BETA wanted to distill some of these important findings by asking some prominent San Francisco Bay Area providers to give us their take on the conference. We asked, ?What did you find interesting? What did you find exciting? And, what did you learn??
KCBS? Jane McMillan talks with Dr. Deborah Cohan, obstetrician and gynecologist, who runs the UCSF Perinatal HIV Clinic and is Medical Director of HIVE, the Bay Area Perinatal AIDS Center at SF General.
Learn about the roles of PrEP (Pre-Exposure Prophylaxis), PEP (Post-Exposure Prophylaxis), TasP (Treatment as Prevention), male and female condoms, and more.